Lanqing Huo

department of radiation oncology

H指数:9

被引数:393

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining optimal treatment strategies for nasopharyngeal carcinoma based on the ninth edition TNM staging system: insights from a multicenter cohort study in an endemic region

基于第九版TNM分期系统定义鼻咽癌最优治疗策略：来自流行病区的多中心队列研究的启示

BMC Medicine

IF8.3

2026-07-220

ASB7 promotes osteosarcoma lung metastasis through ubiquitin-mediated degradation of ATF2

ASB7通过泛素介导的ATF2降解促进骨肉瘤肺转移

Cell Discovery

IF12.5

2026-05-050

OAAI

Advances and challenges in nutritional screening and assessment for cancer patients: a comprehensive systematic review and future directions

肿瘤患者营养筛查与评估的进展与挑战：一项全面的系统综述及未来方向

Frontiers in Nutrition

IF5.1

2025-10-170

OAAI

TOXICITY AND MECHANISMS OF BISPHENOL A IN GLIOBLASTOMA: INSIGHTS FROM MENDELIAN RANDOMIZATION AND NETWORK TOXICOLOGY

双酚A在胶质母细胞瘤中的毒性与机制：孟德尔随机化和网络毒理学的见解

NEURO-ONCOLOGY

IF13.4

2025-10-010

OAAI

B RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA

B 复发胶质母细胞瘤的再放疗

NEURO-ONCOLOGY

IF13.4

2025-10-010

OAAI

Real-world disproportionality analysis of cardiac failure associated with novel antineoplastic agents in breast cancer: a pharmacovigilance study

乳腺癌患者使用新型抗肿瘤药物所致心脏衰竭的真实世界非比例性分析：一项药物警戒研究

Frontiers in Immunology

IF5.9

2025-09-290

OAAI

The assembly of RAB22A/TMEM33/RTN4 initiates a secretory ER-phagy pathway

RAB22A/TMEM33/RTN4的组装启动了分泌性ER-吞噬途径

Cell Discovery

IF12.5

2025-04-290

OAAI

RAB33A promotes metastasis via RhoC accumulation through non-canonical autophagy in cervical cancer

CELL DEATH & DISEASE

IF9.6

2025-02-250

OAAI

THE FUNCTIONS AND MECHANISMS OF OSGIN1 INVOLVED IN FERROPTOSIS RESISTANCE OF GLIOBLASTOMA

NEURO-ONCOLOGY

IF13.4

2024-10-170

PRE

EFFICACY AND FAILURE PATTERNS OF SIMULTANEOUS INTEGRATED BOOST INTENSITY-MODULATED RADIOTHERAPY FOR WHO GRADE IV GLIOMAS

NEURO-ONCOLOGY

IF13.4

2024-10-170

PRE

RAB22A sorts epithelial growth factor receptor (EGFR) from early endosomes to recycling endosomes for microvesicles release

JOURNAL OF EXTRACELLULAR VESICLES

IF14.5

2024-07-250

Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer

CELL DEATH AND DIFFERENTIATION

IF15.4

2023-11-257

PRE

Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases

RADIATION ONCOLOGY

IF3.2

2023-09-263

OAAI

Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2023-04-013

OAAI

A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy

inflammation research

IF4.1

2022-12-012

Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity

CELL RESEARCH

IF25.9

2022-10-2450

OAAI

Incidence, mortality, and survival analyses of patients with thymic lymphoma

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-141

OAAI

Circulating Epstein-Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma

EUROPEAN JOURNAL OF CANCER

IF7.1

2021-07-0115

PRE

Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases

FRONTIERS IN ONCOLOGY

IF3.3

2020-05-1422

OAAI

Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis

JOURNAL OF GYNECOLOGIC ONCOLOGY

IF3.7

2019-01-015

OAAI

Lanqing Huo

个人简介

教育背景

工作经历

荣誉奖项

研究方向